Functional interaction of Escherichia coli heat-labile enterotoxin with blood group A-active glycoconjugates from differentiated HT29 cells

FEBS Journal

Volumn 273, Issue 15, 2006, Pages 3444-3453

  Galván, Estela M ^a   Roth, German A ^a   Monferran, Clara G ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

ABH glycoconjugates; Differentiated HT29 cells; Escherichia coli heat labile toxin; Glycosphingolipids; Toxin receptors

Indexed keywords

ALPHA GLUCOSIDASE; AMINOPEPTIDASE; LACTASE; SUCRASE;

ARTICLE; BLOOD GROUP; CARCINOMA CELL; CELL DIFFERENTIATION; COLON ADENOCARCINOMA; ENZYME ACTIVITY; ESCHERICHIA COLI; HELIX POMATIA; HUMAN; MICROVILLUS; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; RECEPTOR BINDING;

ABO BLOOD-GROUP SYSTEM; BACTERIAL TOXINS; CELL DIFFERENTIATION; CYCLIC AMP; ENTEROTOXINS; ESCHERICHIA COLI PROTEINS; GLYCOCONJUGATES; HT29 CELLS; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION;

ESCHERICHIA COLI; HELIX POMATIA;

EID: 33746136855     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2006.05368.x     Document Type: Article

References (43)

1. Spangler BD (1992) Structure and functions of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol Rev 56, 622-647.
2. Finkelstein RA, Burks MF, Zupan A, Dallas WS, Jacob CO & Ludwig DS (1987) Epitopes of the cholera family of enterotoxins. Rev Infect Dis 9, 544-561.
3. Bastiaens PI, Majoul IV, Verveer PJ, Soling HD & Jovin TM (1996) Imaging the intracellular trafficking and state of AB5 quaternary structure of cholera toxin. EMBO J 15, 4246-4253.
4. Torgersen ML, Skretting G, van Deurs B & Sandvig K (2001) Internalization of cholera toxin by different endocytic mechanisms. J Cell Sci 114, 3737-3747.
5. Tsai B, Ye Y & Rapoport T (2002) Retro-translocation of proteins from the endoplasmic reticulum into the cytosol. Nat Rev Mol Cell Biol 3, 246-255.
6. Fishman PH (1990) Mechanism of action of cholera toxin. In ADP-Ribosylating Toxins and G Proteins: Insights Into Signal Transduction. (Moss J & Vaughan M, eds), pp. 127-140. American Society for Microbiology, Washington DC.
7. Moss J & Vaughan M (1981) Mechanism of action of choleragen and E. coli heat-labile enterotoxin: Activation of adenylate cyclase by ADP-ribosylation. Mol Cell Biochem 37, 75-90.
8. Teneberg S, Hirst TR, Angström J & Karlsson K-A (1994) Comparison of the glycolipid-binding specificities of cholera toxin and porcine Escherichia coli heat-labile enterotoxin: identification of a receptor-active non-ganglioside glycolipid for the heat-labile toxin in infant rabbit small intestine. Glycoconjug J 11, 533-540.
9. Griffiths SL & Crithley DR (1991) Characterization of the binding sites for Escherichia coli heat-labile toxin type I in intestinal brush borders. Biochim Biophys Acta 1075, 154-161.
10. Zemelman BV, Chu SHW & Walker WA (1989) Host response to Escherichia coli heat-labile enterotoxin via two microvillus membrane receptors in the rat intestine. Infect Immun 57, 2947-2952.
11. Monferran CG, Roth GA & Cumar FA (1990) Inhibition of cholera toxin binding to membrane receptors by pig gastric mucin-derived glycopeptides: Differential effect depending on the ABO blood group antigenic determinants. Infect Immun 58, 3966-3972.
12. Barra JL, Monferran CG, Balanzino LE & Cumar FA (1992) Escherichia coli heat-labile enterotoxin preferentially interacts with blood group A-active glycolipids from pig intestinal mucosa and A- and B-active glycolipids from human red cells compared to H-active glycolipids. Mol Cell Biochem 115, 63-70.
13. Balanzino LE, Barra JL, Monferran CG & Cumar FA (1994) Differential interaction of Escherichia coli heat-labile toxin and cholera toxin with pig intestinal brush border glycoproteins depending on their ABH and related blood group antigenic determinants. Infect Immun 62, 1460-1464.
14. Balanzino LE, Barra JL, Galván EM, Roth GA & Monferran CG (1999) Interaction of cholera toxin and Escherichia coli heat-labile enterotoxin with glycoconjugates from rabbit intestinal brush border membranes: Relationship with ABH blood groups determinants. Mol Cell Biochem 194, 53-62.
15. Galván EM, Roth GA & Monferran CG (1999) Participation of ABH glycoconjugates in the secretory response to Escherichia coli heat- labile toxin in rabbit intestine. J Infect Dis 180, 419-425.
16. Galván EM, Diema CD, Roth GA & Monferran CG (2004) Ability of Blood Group A-Active Glycosphingo-lipids to Act as Escherichia coli Heat-Labile Enterotoxin Receptors in HT-29 cells. J Infect Dis 189, 1556-1564.
17. Zweibaum A, Pinto M, Chevallier G, Dussaulx E, Triadou N, Lacroix B, Haffen K, Brun JL & Rousset M (1985) Enterocytic differentiation of a subpopulation of the human colon- tumor cell line HT-29 selected for growth in sugar-free medium and its inhibition by glucose. J Cell Physiol 122, 21-29.
18. Huet C, Sahuquillo-Merino C, Coudrier E & Louvard D (1987) Absorptive and mucus.secreting subclones isolated from a multipotent intestinal cell line (HT-29) provide new models for cell polarity and terminal differentiation. J Cell Biol 105, 345-357.
19. Augeron C & Laboisse CL (1984) Emergence of Permanently Differentiated Cell Clones in a Human Colonic Cancer Cell Line in Culture after Treatment with Sodium Butyrate. Cancer Res 44, 3961-3969.
20. Lesuffleur T, Kornowski A, Luccioni C, Muleris M, Barbat A, Beaumatin J, Dussaulx E, Dutrillaux B & Zweibaum A (1991) Adaptation to 5-fluorouracil of the heterogeneous human colon tumor cell line HT-29 results in the selection of cells committed to differentiation. Int J Cancer 49, 721-730.
21. Hekmati M, Polak-Charcon S & Ben-Shaul Y (1990) A morphological study of a human adenocarcinoma cell line (HT29) differentiating in culture. Similarities to intestinal embryonic development. Cell Differ Dev 31, 207-218.
22. Polak-Charcon S, Hekmati M & Ben Shaul Y (1989) The effect of modifying the culture medium on cell polarity in a human colon carcinoma cell line. Cell Differ Dev 26, 119-129.
23. Lesuffleur T, Violette S, Vasile-Pandrea I, Dussaulx E, Barbat A, Muleris M & Zweibaum A (1998) Resistance to high concentrations of methotrexate and 5-fluorouracil of differentiated HT-29 colon-cancer cells is restricted to cells of enterocyte phenotype. Int J Cancer 76, 383-392.
24. Pinto M, Robine-Leon S, Appay MD, Kedinger M, Triadou N, Dessaulx E, Lacroix B, Simon-Assmann P, Haffen K, Fogh J et al. (1983) Enterocyte-like differentiation and polarization of the of the human colon carcinoma cell line Caco2 in culture. Biol Cell 47, 323-330.
25. Hauri H-P, Sterchi EE, Bienz D, Fransen JAM & Marxer A (1985) Expression and Intracellular Transport of Microvillus Membrane Hydrolases in Human intestinal epithelial cells. J Cell Biol 101, 838-851.
26. Chantret I, Chevallier G, Dussaulx E & Zweibaum A (1987) A and H Blood Group Antigens as Markers of Sucrase-Isomaltase from the Enterocyte-like Differentiated Human Colon Carcinoma Cell Lines HT-29 and Caco-2. Cancer Res 47, 1426-1433.
27. Trugnan G, Rousset M, Chantret I, Barbat A & Zweibaum A (1987) The Posttranslational Processing of Sucrase-Isomaltase in HT-29 Cells is a function of Their State of Enterocytic Differentiation. J Cell Biol 104, 1199-1205.
28. Violette S, Poulain L, Dussaulx E, Pepin D, Faussat AM, Chambaz J, Lacorte JM, Staedel C & Lesuffleur T (2002) Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and p53 status. Int J Cancer 98, 498-504.
29. Violette S, Festor E, Pandrea-Vasile I, Mitchell V, Adida C, Dussaulx E, Lacorte JM, Chambaz J, Lacasa M & Lesuffleur T (2003) Reg IV, a new member of the regenerating gene family, is overexpressed in colorectal carcinomas. Int J Cancer 103, 185-193.
30. Leteurtre E, Gouyer V, Rousseau K, Moreau O, Barbat A, Swallow D, Huet G & Lesuffleur T (2004) Differential mucin expression in colon carcinoma HT-29 clones with variable resistance to 5-fluorouracil and methotrexate. Biol Cell 92, 145-151.
31. Gout S, Laine MC, Tavernier G, Block MR & Jacquier-Starlin M (2004) Early enterocytic differentiation of HT-29 cells: biochemical changes and strength increases of adherens junctions. Exp Cell Res 299, 498-510.
32. Simons K & van Meer G (1988) Lipid sorting in epithelial cells. Biochemistry 27, 6197-6202.
33. Holmner A, Lebens M, Teneberg S, Angstrom J, Ökvist M & Krengel U (2004) Novel binding site identified in a hybrid between cholera toxin and heat-labile enterotoxin: 1.9 Å crystal structure reveals the details. Structure 12, 1655-1667.
34. Barua D & Paguio AS (1977) ABO blood groups and cholera. Ann Hum Biol 4, 489-492.
35. Chaudhuri AS & De S (1977) Cholera and blood-groups. Lancet 2, 404.
36. Glass RI, Holmgren J, Haley CE, Khan MR, Svennerholm A-M, Stoll BJ, Belayet Hossain KM, Black RE, Yunus M & Barua D (1985) Predisposition for cholera of individuals with O blood group. Am J Epidemiol 121, 791-796.
37. Levine MM, Nalin DR, Rennels MB, Hornick RB, Sotman S, van Blerk G, Hughes TP & O'Donnell S (1979) Genetic susceptibility to cholera. Ann Hum Biol 6, 369-374.
38. Harris JB, Khan AI, LaRocque RC, Dorer DJ, Chowdhury F, Faruque ASG, Sack DA, Ryan ET, Quadri F & Calderwood SB (2005) Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity. Infect Immun 73, 7422-7427.
39. Black RE, Levine MM, Clements ML, Hughes T & O'Donnell S (1981) Association between O blood group and occurrence and severity of diarrhoea due to Escherichia coli. Trans R Soc Trop Med Hyg 81, 120-123.
40. Roth J (1975) Methods for assessing immunologic and biologic properties of iodinated peptide hormones. Methods Enzymol 37B, 223-233.
41. Lowry OH, Rosebrough NJ, Farr AL & Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193, 265-275.
42. Messer M & Dahlqvist A (1966) A one-step ultramicro-method for the assay of intestinal dissacharidases. Anal Biochem 14, 376-392.
43. Maroux S, Louvard D & Baratti J (1973) The amino-peptidase from hog intestinal brush border. Biochim Biophys Acta 321, 282-295.